Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:33 PM
Ignite Modification Date:
2025-12-24 @ 4:33 PM
NCT ID:
NCT02153866
Eligibility Criteria:
Inclusion Criteria:
* Aged 8\~9 months healthy child
* Subjects or guardians who can and will comply with the requirements of the protocol
* Without vaccination history of rotavirus vaccine, measles-rubella vaccine and measles-mumps-rubella vaccine.
* Axillary temperature is under 37.0℃.
* Accord with the requirement of drug manual of rotavirus vaccine,measles-rubella vaccine and measles-mumps-rubella vaccine.
Exclusion Criteria:
* Allergic to any component of the vaccines.
* Women of pregnancy, lactation or about to be pregnant in 60 days.
* Infected by some rash disease within one month.
* Known severe immunodeficiency (e.g., from hematologic and solid tumors, receipt of chemotherapy, congenital immunodeficiency, or long-term immunosuppressive therapy or patients with HIV infection who are severely immunocompromised).
* Any prior administration of immunoglobulins, any other vaccines or experimental drugs in the last 4 weeks.
* Family history of seizures or progressive neurological disease.
* Diarrheal caused by rotavirus or lasting for 3 or more days.
* Any condition that in the opinion of the investigator, may interfere with the evaluation of study objectives.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
8 Months
Maximum Age:
9 Months
Study:
NCT02153866
Study Brief:
Protocol Section:
NCT02153866